Cargando…

Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle

AIMS/HYPOTHESIS: Insulin resistance and type 2 diabetes are associated with mitochondrial dysfunction. The aim of the present study was to test the hypothesis that oxidative phosphorylation and electron transport capacity are diminished in the skeletal muscle of type 2 diabetic subjects, as a result...

Descripción completa

Detalles Bibliográficos
Autores principales: Boushel, R., Gnaiger, E., Schjerling, P., Skovbro, M., Kraunsøe, R., Dela, F.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1820754/
https://www.ncbi.nlm.nih.gov/pubmed/17334651
http://dx.doi.org/10.1007/s00125-007-0594-3
_version_ 1782132645700829184
author Boushel, R.
Gnaiger, E.
Schjerling, P.
Skovbro, M.
Kraunsøe, R.
Dela, F.
author_facet Boushel, R.
Gnaiger, E.
Schjerling, P.
Skovbro, M.
Kraunsøe, R.
Dela, F.
author_sort Boushel, R.
collection PubMed
description AIMS/HYPOTHESIS: Insulin resistance and type 2 diabetes are associated with mitochondrial dysfunction. The aim of the present study was to test the hypothesis that oxidative phosphorylation and electron transport capacity are diminished in the skeletal muscle of type 2 diabetic subjects, as a result of a reduction in the mitochondrial content. MATERIALS AND METHODS: The O(2) flux capacity of permeabilised muscle fibres from biopsies of the quadriceps in healthy subjects (n = 8; age 58 ± 2 years [mean±SEM]; BMI 28 ± 1 kg/m(2); fasting plasma glucose 5.4 ± 0.2 mmol/l) and patients with type 2 diabetes (n = 11; age 62 ± 2 years; BMI 32 ± 2 kg/m(2); fasting plasma glucose 9.0 ± 0.8 mmol/l) was measured by high-resolution respirometry. RESULTS: O(2) flux expressed per mg of muscle (fresh weight) during ADP-stimulated state 3 respiration was lower (p < 0.05) in patients with type 2 diabetes in the presence of complex I substrate (glutamate) (31 ± 2 vs 43 ± 3 pmol O(2) s(−1) mg(−1)) and in response to glutamate + succinate (parallel electron input from complexes I and II) (63 ± 3 vs 85 ± 6 pmol s(−1) mg(−1)). Further increases in O(2) flux capacity were observed in response to uncoupling by FCCP, but were again lower (p < 0.05) in type 2 diabetic patients than in healthy control subjects (86 ± 4 vs 109 ± 8 pmol s(−1) mg(−1)). However, when O(2) flux was normalised for mitochondrial DNA content or citrate synthase activity, there were no differences in oxidative phosphorylation or electron transport capacity between patients with type 2 diabetes and healthy control subjects. CONCLUSIONS/INTERPRETATION: Mitochondrial function is normal in type 2 diabetes. Blunting of coupled and uncoupled respiration in type 2 diabetic patients can be attributed to lower mitochondrial content.
format Text
id pubmed-1820754
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-18207542007-03-12 Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle Boushel, R. Gnaiger, E. Schjerling, P. Skovbro, M. Kraunsøe, R. Dela, F. Diabetologia Article AIMS/HYPOTHESIS: Insulin resistance and type 2 diabetes are associated with mitochondrial dysfunction. The aim of the present study was to test the hypothesis that oxidative phosphorylation and electron transport capacity are diminished in the skeletal muscle of type 2 diabetic subjects, as a result of a reduction in the mitochondrial content. MATERIALS AND METHODS: The O(2) flux capacity of permeabilised muscle fibres from biopsies of the quadriceps in healthy subjects (n = 8; age 58 ± 2 years [mean±SEM]; BMI 28 ± 1 kg/m(2); fasting plasma glucose 5.4 ± 0.2 mmol/l) and patients with type 2 diabetes (n = 11; age 62 ± 2 years; BMI 32 ± 2 kg/m(2); fasting plasma glucose 9.0 ± 0.8 mmol/l) was measured by high-resolution respirometry. RESULTS: O(2) flux expressed per mg of muscle (fresh weight) during ADP-stimulated state 3 respiration was lower (p < 0.05) in patients with type 2 diabetes in the presence of complex I substrate (glutamate) (31 ± 2 vs 43 ± 3 pmol O(2) s(−1) mg(−1)) and in response to glutamate + succinate (parallel electron input from complexes I and II) (63 ± 3 vs 85 ± 6 pmol s(−1) mg(−1)). Further increases in O(2) flux capacity were observed in response to uncoupling by FCCP, but were again lower (p < 0.05) in type 2 diabetic patients than in healthy control subjects (86 ± 4 vs 109 ± 8 pmol s(−1) mg(−1)). However, when O(2) flux was normalised for mitochondrial DNA content or citrate synthase activity, there were no differences in oxidative phosphorylation or electron transport capacity between patients with type 2 diabetes and healthy control subjects. CONCLUSIONS/INTERPRETATION: Mitochondrial function is normal in type 2 diabetes. Blunting of coupled and uncoupled respiration in type 2 diabetic patients can be attributed to lower mitochondrial content. Springer-Verlag 2007-02-15 2007-04 /pmc/articles/PMC1820754/ /pubmed/17334651 http://dx.doi.org/10.1007/s00125-007-0594-3 Text en © Springer-Verlag 2007
spellingShingle Article
Boushel, R.
Gnaiger, E.
Schjerling, P.
Skovbro, M.
Kraunsøe, R.
Dela, F.
Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle
title Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle
title_full Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle
title_fullStr Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle
title_full_unstemmed Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle
title_short Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle
title_sort patients with type 2 diabetes have normal mitochondrial function in skeletal muscle
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1820754/
https://www.ncbi.nlm.nih.gov/pubmed/17334651
http://dx.doi.org/10.1007/s00125-007-0594-3
work_keys_str_mv AT boushelr patientswithtype2diabeteshavenormalmitochondrialfunctioninskeletalmuscle
AT gnaigere patientswithtype2diabeteshavenormalmitochondrialfunctioninskeletalmuscle
AT schjerlingp patientswithtype2diabeteshavenormalmitochondrialfunctioninskeletalmuscle
AT skovbrom patientswithtype2diabeteshavenormalmitochondrialfunctioninskeletalmuscle
AT kraunsøer patientswithtype2diabeteshavenormalmitochondrialfunctioninskeletalmuscle
AT delaf patientswithtype2diabeteshavenormalmitochondrialfunctioninskeletalmuscle